Although LRRK2 is considered one of the most promising drug targets for PD, currently we know very little about its biological function and structure, or how LRRK2 mutations affect its functions that ...
Dr. Zhenyu Yue of Mount Sinai School of Medicine discusses two new BAC Lrrk2 mouse models, recently published in Journal of Neuroscience. As The Michael J. Fox Foundation partially funded this ...
Brain treatment and
Immunohistochemistry: FLAG-LRRK2-WT
transgenic mouse and littermate non-transgenic control mouse were anesthetized and perfused with
30ml cold PBS (pH 7.4) and 30ml 4% ...